4-butyrolactone has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JG; Hsu, SC; Huang, YP; Kuo, YH; Lin, ML; Yu, CC; Yu, FS | 1 |
| Hara, A; Makita, H; Mori, H; Ohnishi, M; Satoh, K; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
2 other study(ies) available for 4-butyrolactone and Cancer of Mouth
| Article | Year |
|---|---|
4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck | 2016 |
Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
Topics: 4-Butyrolactone; 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Male; Mouth Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids; Silver Staining | 1995 |